Trabectedin plus pegylated liposomal doxorubicin in recurrent ovarian carcinoma after poly-ADP-ribose polymerase inhibitors progression: A real-world single-center experience

Gynecologic Oncology Reports · Elsevier

Аннотация

Publication date: October 2026 Source: Gynecologic Oncology Reports, Volume 67 Author(s): Naroa Amondarain Amenabar, Karmele Mujika Eizmendi, Laura Gabirondo Amenabar, Marina Crespo Cruz, Iker Muñagorri Quiles, Elide Gutiérrez San José, Malena García Álvarez, Iera Arrondo Arizmendi, Nerea Bengoa Fernández, Javier Martínez Amorena, Maddi Sánchez Urrestarazu, Larraitz Egaña Otaño, Cristina Churruca Galaz

Читать у издателя →

Похожие статьи